Researcher finds protein that may contribute to cancer drugs not working
Feb 23, 2012
A researcher from Newcastle University, Dr. Kelly Avery-Kiejda, has been studying the protein P-53 for the past seven years. She recently discovered that it may be a factor in anti-cancer therapies being ineffective, according to ABC News.
"If it's on, it will stop cancer. In around 80 percent of cancer it's known to be inactivated, so its gene is actually non-functional" Dr. Avery-Kiejda told the news source. "In breast cancer this only occurs in around 25 per cent of cases so we've found the smaller version of this protein it can stop breast cancer in cases where its function isn't inhibited by a mutation in the gene."
She has been awarded with more funds to continue her research on the protein.
According to the American Cancer Society, breast cancer is the second leading cause of cancer-related death among women, following only lung cancer. However, the death rate has been steadily decreasing since 1990 due to advancements in technology and breast cancer breakthrough news. There are currently 2.5 million survivors in the United States.